Clinical trial
24-month Prospective, Multicentre, Non-interventional Study to Evaluate the Effectiveness of Elocta Compared to Conventional Factor Products in the Prophylactic Treatment of Patients With Haemophilia A (A-SURE)
NCT02976753 is registered in ClinicalTrials.gov with Swedish Orphan Biovitrum as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- 24-month Prospective, Multicentre, Non-interventional Study to Evaluate the Effectiveness of Elocta Compared to Conventional Factor Products in the Prophylactic Treatment of Patients With Haemophilia A (A-SURE)
- Lead sponsor
- Swedish Orphan Biovitrum
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 31, 2016
- Completion date
- November 3, 2021
- Enrollment
- 361 (actual)
- Sites
- 36
Conditions
As the registry lists them; a condition with its own page is linked.